{
    "nct_id": "NCT04535414",
    "official_title": "Phase II Randomized Trial of Bethesda Protocol Compared to Cambridge Method for Detection of Early Stage Gastric Cancer in CDH1 Mutation Carriers",
    "inclusion_criteria": "* INCLUSION CRITERIA:\n* An individual who harbors a pathogenic, or likely pathogenic, cadherin-1 gene (CDH1) germline variant.\n\nNote: individuals with CDH1 variant classified as any of the following are not eligible:\n\n* variant of uncertain significance\n* benign\n* likely benign.\n\n  * Age greater than or equal to 18 years.\n  * Physiologically able to undergo upper endoscopy.\n  * Ability of subject to understand and the willingness to sign a written informed consent document.\n\nEXCLUSION CRITERIA:\n\n* Any clinical contraindication (e.g., known bleeding disorder, thrombocytopenia) to endoscopic biopsy.\n* Unstable angina or recent (within 3 months) myocardial infarction.\n* Any clinical contraindication to general anesthesia.\n\nRe-Enrollment:\n\nINCLUSION CRITERIA:\n\n* Subject must have previously been enrolled on the study and must have undergone endoscopy. Note: Subject may re-enroll only once after initial endoscopy performed\n* Subject must have clinical need for a repeat endoscopy\n* Prior on-protocol endoscopy must have occurred at least 6 months (+/- 2 weeks) and no greater than 18 months (+/- 4 weeks)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}